Voyager Therapeutics Stock Technical Analysis
| VYGR Stock | USD 5.43 0.07 1.31% |
As of the 22nd of November, Voyager Therapeutics has the Coefficient Of Variation of (1,770), variance of 23.76, and Risk Adjusted Performance of (0.03). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Voyager Therapeutics, as well as the relationship between them. Please validate Voyager Therapeutics market risk adjusted performance and treynor ratio to decide if Voyager Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 5.43 per share. Given that Voyager Therapeutics has information ratio of (0.08), we advise you to double-check Voyager Therapeutics's current market performance to make sure the company can sustain itself at a future point.
Voyager Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Voyager, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VoyagerVoyager |
Voyager Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 13.67 | Strong Buy | 9 | Odds |
Most Voyager analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Voyager stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Voyager Therapeutics, talking to its executives and customers, or listening to Voyager conference calls.
Voyager Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Voyager Therapeutics Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Voyager Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Voyager Therapeutics Trend Analysis
Use this graph to draw trend lines for Voyager Therapeutics. You can use it to identify possible trend reversals for Voyager Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Voyager Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Voyager Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Voyager Therapeutics applied against its price change over selected period. The best fit line has a slop of 0 , which means Voyager Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.88, which is the sum of squared deviations for the predicted Voyager Therapeutics price change compared to its average price change.About Voyager Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Voyager Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Voyager Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Voyager Therapeutics price pattern first instead of the macroeconomic environment surrounding Voyager Therapeutics. By analyzing Voyager Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Voyager Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Voyager Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 9.98 | 6.47 | 19.5 | 23.17 | Receivables Turnover | 50.02 | 64.02 | 2.96 | 2.81 |
Voyager Therapeutics November 22, 2024 Technical Indicators
Most technical analysis of Voyager help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Voyager from various momentum indicators to cycle indicators. When you analyze Voyager charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 3.06 | |||
| Coefficient Of Variation | (1,770) | |||
| Standard Deviation | 4.87 | |||
| Variance | 23.76 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 36.72 | |||
| Value At Risk | (6.93) | |||
| Potential Upside | 4.51 | |||
| Skewness | 0.299 | |||
| Kurtosis | 6.26 |
Voyager Therapeutics November 22, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Voyager stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 26,413 | ||
| Daily Balance Of Power | 0.23 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 5.34 | ||
| Day Typical Price | 5.37 | ||
| Price Action Indicator | 0.12 |
Additional Tools for Voyager Stock Analysis
When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.